SC 13G Filing

Company

Protalix BioTherapeutics, Inc.

Filed

February 9, 2012

Accession Number

0001318148-12-000229

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →